Freestone Grove Partners’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.02M Sell
96,612
-43,320
-31% -$2.35M 0.05% 311
2026
Q1
$5.4M Buy
+139,932
New +$5.82M 0.04% 320
2025
Q3
Sell
-30,000
Closed -$1.55M 939
2025
Q2
$1.55M Buy
+30,000
New +$1.21M 0.01% 391

Other funds holding HNGE

Freestone Grove Partners's HNGE Position: Q2 2026 in Review

Freestone Grove Partners reduced its Hinge Health (HNGE) stake by 31% in Q2 2026, selling an estimated $2.35M and leaving 96,612 shares worth $8.02M. The position accounts for 0.05% of the portfolio, ranked #311.

Freestone Grove Partners first reported a position in HNGE in Q2 2025 and has held it in 3 quarters since. 277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • Freestone Grove Partners held 96,612 shares of Hinge Health worth $8.02M as of Q2 2026.
  • Freestone Grove Partners sold 43,320 Hinge Health shares in Q2 2026, an estimated $2.35M.
  • Hinge Health made up 0.05% of Freestone Grove Partners's portfolio in Q2 2026, its #311 holding.
  • Freestone Grove Partners first reported a position in Hinge Health in Q2 2025 and has held it in 3 quarters since.
  • 277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.